ARRY

Array Biopharma Inc
ARRY

Overview Fund Activity
Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

128 hedge funds and large institutions have $445M invested in Array Biopharma Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 43 reducing their positions, and 17 closing their positions.

Holders
128
Holders Change
-4
Holders Change %
-3.03%
% of All Funds
3.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
14
Increased
38
Reduced
43
Closed
17
Calls
$3.25M
Puts
$2.55M
Net Calls
+$700K
Net Calls Change
+$1.17M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$6.33M
2
SCM
2
Sarissa Capital Management
Connecticut
$15.3M
3
Macquarie Group
3
Macquarie Group
Australia
$2.35M
4
CEP
4
Chicago Equity Partners
Illinois
$1.98M
5
NC
5
Nexthera Capital
New York
$1.86M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$62K
2
AC
2
Armistice Capital
New York
$0
3
VAM
3
Visium Asset Management
New York
$0
4
State Street
4
State Street
Massachusetts
$12.7M
5
DM
5
Deerfield Management
New York
$29.8M
Name Market Value Shares Shares
Change 		Shares
Change %
CL
151
CSS LLC
Illinois
– – – –
Simplex Trading
152
Simplex Trading
Illinois
– – – –
PRS
153
Pinkerton Retirement Specialists
Idaho
$0 109 +109 New
3 4 5 6
7